PKC-IN-6
PKC-IN-6 (Compound 21) is a selective inhibitor of tyrosine and serine kinases. PKC-IN-6 shows inhibitory activity against PKC-α, PKC-δ, PKA, EGF-R with IC50 values of 240, >500, >500, >100 μM, respectively. PKC-IN-6 is promising for research of cancers[1].
Product Specifications
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
EGFR; PKA; PKC; Ser/Thr Kinase; Tyrosinase
Related Pathways
Epigenetics; JAK/STAT Signaling; Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Concentration
10mM
Purity
99.93
Solubility
DMSO : 33.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
NC1=CC(=C(C=C1)C)NC2=NC=CC(=N2)C3=CC=CN=C3
Molecular Formula
C16H15N5
Molecular Weight
277.33
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-W013852/PKC-IN-6-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EGFR/ErbB1/HER1; PKA; PKCα; PKCδ
CAS Number
[152460-10-1]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
